Stockscreener 앱 받기
3.86
1.31%
0.05
전일 마감가:
$3.81
열려 있는:
$3.83
하루 거래량:
4.09M
Relative Volume:
0.94
시가총액:
$1.38B
수익:
$9.68M
순이익/손실:
$-250.64M
주가수익비율:
-2.7575
EPS:
-1.3998
순현금흐름:
$-89.83M
1주 성능:
-14.41%
1개월 성능:
-6.76%
6개월 성능:
+2.80%
1년 성능:
+190.23%
1일 변동 폭
$3.77
$3.935
1주일 범위
$3.69
$4.58
52주 변동 폭
$1.30
$5.465
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.86 | 1.36B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
441.74 | 108.72B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
628.73 | 64.89B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
842.27 | 50.57B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.64 | 39.06B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
155.69 | 33.16B | 742.00K | -1.37B | -1.07B | -7.0731 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Precigen jumps after Q1 beat as Papzimeos launch momentum takes hold - MSN
Precigen, Inc. (PGEN) is a great momentum stock: Should you buy? - MSN
Precigen, Inc.'s (NASDAQ:PGEN) Path To Profitability - 富途牛牛
Have Precigen Insiders Been Selling Stock? - simplywall.st
H.C. Wainwright reiterates Precigen stock rating on trial data - Investing.com UK
H.C. Wainwright reiterates Precigen stock rating on trial data By Investing.com - Investing.com Australia
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $14 - Moomoo
Precigen CCO Phil Tennant sells $131,985 in stock By Investing.com - Investing.com Australia
Precigen CFO Harry Thomasian Jr. sells $182,614 in stock - Investing.com UK
Precigen CEO Helen Sabzevari sells $519,930 in company stock - Investing.com UK
Precigen CEO Helen Sabzevari sells $519,930 in company stock By Investing.com - Investing.com South Africa
Precigen chief legal officer Lehr sells $127,011 in stock By Investing.com - Investing.com India
Precigen COO Rutul R Shah sells $186,185 in common stock By Investing.com - Investing.com India
Precigen chief legal officer Lehr sells $127,011 in stock - Investing.com
Precigen CFO Harry Thomasian Jr. sells $182,614 in stock By Investing.com - Investing.com Australia
Precigen COO Rutul R Shah sells $186,185 in common stock - Investing.com
Precigen CCO Phil Tennant sells $131,985 in stock - Investing.com
Precigen (PGEN) CEO sells 119,250 shares in tax sell-to-cover transaction - Stock Titan
Precigen (PGEN) CFO sells 41,884 shares to cover RSU tax withholding - Stock Titan
PRECIGEN (PGEN) CCO sells 30,272 shares in tax-related transaction - Stock Titan
Precigen (PGEN) COO sells 42,703 shares to cover RSU tax withholding - Stock Titan
Precigen (PGEN) Chief Legal Officer sells shares to cover RSU tax withholding - Stock Titan
Precigen, Inc. (PGEN) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Promising Long-Term Data for Precigen (PGEN) in RRP Treatment - GuruFocus
Precigen Q1 earnings call highlights - MSN
Number of shareholders of Precigen, Inc. – NASDAQ:PGEN - TradingView
Number of shareholders of Precigen Inc – BX:I5X - TradingView
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years - PR Newswire
Precigen (PGEN) price target increased by 11.76% to 9.69 - MSN
Precigen(PGEN) Stock Options Chain | Quotes & News - Moomoo
PGEN News | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen (PGEN) Maintained by HC Wainwright & Co. -- Price Targe - GuruFocus
Precigen (PGEN) CFO gains 87,500 shares from RSU vesting - Stock Titan
PRECIGEN (PGEN) CCO Phil Tennant acquires 62,500 shares through RSU vesting - Stock Titan
Precigen (PGEN) COO converts 90,000 RSUs to common shares in Form 4 filing - Stock Titan
Precigen’s PAPZIMEOS Receives FDA Orphan Drug Exclusivity for RRP Treatment, Blocking Similar Drugs for Seven Years - geneonline.com
FDA grants orphan drug exclusivity for Precigen’s PAPZIMEOS - Investing.com UK
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million - ACCESS Newswire
Precigen (PGEN) Secures Orphan Drug Status for Papzimeos Treatme - GuruFocus
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapog - GuruFocus
FDA grants orphan drug exclusivity for Precigen’s PAPZIMEOS By Investing.com - Investing.com Australia
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.89%
0.19%
자본화:
|
볼륨(24시간):